doctitl prospect grant partial exclus licens antisens phosphorothio oligodeoxyribonucleotid doctitl agenc agenc nation institut health public health servic dhh agenc action action notic action summari summari nation institut health nih announc intent grant partial exclus licens isi pharmaceut inc hybridon inc patent applic patent claim antisens phosphorothio oligodeoxyribonucleotid summari date date written object comment propos partial exclus licens must submit juli 25 1994 written comment applic licens receiv nih within sixti 60 day notic consid make final determin regard propos partial exclus licens isi pharmaceut inc hybridon inc date address address request copi patent applic patent inquiri object comment materi relat contempl partial exclus licens direct mr arthur j cohn j technolog licens specialist offic technolog transfer nation institut health 6011 execut boulevard suit 325 rockvil md 20852 telephon 301 4967735 facsimil 301 4020220 sign confidenti agreement requir receiv copi patent applic address supplem supplementari inform notic accord 35 u c 209 c 1 37 cfr 404 7 1 nation institut health nih depart health human servic contempl grant partial exclus world wide licens practic invent embodi u patent applic sn 07 030 073 abandon entitl phosphorothio analogu oligodeoxyribonucleotid inhibitor replic cytopath effect htlv iii retrovirus foreign nucleic acid u patent 5 264 423 5 276 019 5 286 717 entitl inhibitor replic retrovirus express oncogen product isi pharmaceut inc carlsbad california hybridon inc worcest massachusett patent right invent assign unit state america prospect partial exclus licens royalti bear compli term condit 35 u c 209 37 cfr 404 7 prospect partial exclus licens may grant unless within 60 day date publish notic nih receiv written evid argument establish satisfact nih grant respect licens would consist requir 35 u c 209 37 cfr 404 7 patent applic patent current coexclus licens gilead scienc inc lynx therapeut inc gen probe inc includ affili genta inc nih determin term coexclus licens prohibit grant addit partial exclus licens nih give full consider addit applic licens demonstr applic qualifi develop commerci invent accord 35 u c 209 37 cfr part 404 patent applic patent disclos novel phosphorothio oligodeoxyribonucleotid composit use prevent replic foreign nucleic acid presenc normal live cell well inhibit prolifer neoplast cell date may 17 1994 supplem signer barbara mcgarey signer signjob deputi director offic technolog transfer signjob frfile fr doc 9412690 file 52494 8 45 frfile bill bill code 414001p bill